IN2014MN02391A - - Google Patents

Info

Publication number
IN2014MN02391A
IN2014MN02391A IN2391MUN2014A IN2014MN02391A IN 2014MN02391 A IN2014MN02391 A IN 2014MN02391A IN 2391MUN2014 A IN2391MUN2014 A IN 2391MUN2014A IN 2014MN02391 A IN2014MN02391 A IN 2014MN02391A
Authority
IN
India
Prior art keywords
reduced form
chalcogenides
compositions
methods
chalcogenide
Prior art date
Application number
Other languages
English (en)
Inventor
Mark B Roth
Michael L Morrison
Akiko Iwata
Original Assignee
Hutchinson Fred Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hutchinson Fred Cancer Res filed Critical Hutchinson Fred Cancer Res
Publication of IN2014MN02391A publication Critical patent/IN2014MN02391A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00Sulfur; Compounds thereof
    • C01B17/22Alkali metal sulfides or polysulfides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00Sulfur; Compounds thereof
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00Sulfur; Compounds thereof
    • C01B17/22Alkali metal sulfides or polysulfides
    • C01B17/24Preparation by reduction
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00Sulfur; Compounds thereof
    • C01B17/22Alkali metal sulfides or polysulfides
    • C01B17/32Hydrosulfides of sodium or potassium
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B19/00Selenium; Tellurium; Compounds thereof
    • C01B19/007Tellurides or selenides of metals
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B19/00Selenium; Tellurium; Compounds thereof
    • C01B19/04Binary compounds including binary selenium-tellurium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06Ampoules or carpules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10Bag-type containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/08Tubes; Storage means specially adapted therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN2391MUN2014 2012-06-13 2013-06-12 IN2014MN02391A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261659311P 2012-06-13 2012-06-13
US201361798043P 2013-03-15 2013-03-15
PCT/US2013/045395 WO2013188528A1 (en) 2012-06-13 2013-06-12 Compositions comprising chalcogenides and related methods

Publications (1)

Publication Number Publication Date
IN2014MN02391A true IN2014MN02391A (ru) 2015-08-21

Family

ID=49758688

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2391MUN2014 IN2014MN02391A (ru) 2012-06-13 2013-06-12

Country Status (13)

Country Link
US (1) US20150290240A1 (ru)
EP (1) EP2861718A4 (ru)
JP (1) JP2015527975A (ru)
KR (1) KR20150021509A (ru)
CN (1) CN104471058A (ru)
AU (1) AU2013274325A1 (ru)
BR (1) BR112014030992A2 (ru)
CA (1) CA2875212A1 (ru)
HK (1) HK1209782A1 (ru)
IN (1) IN2014MN02391A (ru)
MX (1) MX2014014524A (ru)
RU (1) RU2015100257A (ru)
WO (1) WO2013188528A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2728790C2 (ru) 2014-02-10 2020-07-31 Фред Хатчинсон Кансэр Рисёч Сентер Лечение сердечного приступа и ишемического повреждения соединениями галогена
CN109650353A (zh) * 2019-01-14 2019-04-19 成都中建材光电材料有限公司 一种高纯二硫化硒的制备方法
US20230256003A1 (en) * 2020-06-25 2023-08-17 Industry-University Cooperation Foundation Hanyang University Erica Campus Pharmaceutical composition for preventing or treating sepsis containing functionalized transition metal dichalcogenide
CN114471430B (zh) * 2022-02-07 2024-01-02 天津大学 一种连续生产碱金属硫化物的装置及其合成方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1499852A (en) * 1975-03-04 1978-02-01 Smith & Nephew Pharma Packaging
US5208336A (en) * 1990-10-19 1993-05-04 Sterling Drug Inc. Selenomerocyanines and processes for preparation and methods of use and compositions thereof
US5616214A (en) * 1995-09-12 1997-04-01 Pulp And Paper Research Institute Of Canada Determination of sodium sulfide and sulfidity in green liquors and smelt solutions
PE20001435A1 (es) * 1998-11-16 2000-12-14 Paques Bio Syst Bv Proceso para la produccion de sulfuro de hidrogeno a partir de azufre en su condicion elemental y uso del mismo en la recuperacion de metales pesados
US6579705B2 (en) * 2001-04-04 2003-06-17 Consortium Fur Elektrochemische Industrie Gmbh Process for preparing non-proteinogenic L-amino acids
EP2174981B1 (en) * 2002-02-26 2013-07-24 Kuraray Co., Ltd. Resin composition and multi-layer structures
US20060074102A1 (en) * 2004-05-14 2006-04-06 Kevin Cusack Kinase inhibitors as therapeutic agents
JP2009534422A (ja) * 2006-04-20 2009-09-24 フレッド ハッチンソン キャンサー リサーチ センター ショックおよび他の有害な病態を処置するためのカルゴゲニドの使用
CN101534844B (zh) * 2006-10-05 2014-04-23 弗雷德哈钦森癌症研究中心 液体硫属化物的组合物及其制备和使用方法
JP5083753B2 (ja) * 2007-02-26 2012-11-28 独立行政法人理化学研究所 4,5−ジメチル−[1,3]ジセレノール−2−セロンの新規製造方法
JP4028588B2 (ja) * 2007-04-27 2007-12-26 政弘 井筒 リグノセルロース系バイオマスの利用方法
BRPI0908565A2 (pt) * 2008-03-06 2017-05-23 Anacor Pharmaceuticals Inc composto, formulação farmacêutica, métodos para reduzir a liberação de uma citocina ou de uma quimiocina, para tratar uma condição em um animal e para inibir uma fosfodiesterase

Also Published As

Publication number Publication date
AU2013274325A1 (en) 2014-12-11
EP2861718A1 (en) 2015-04-22
BR112014030992A2 (pt) 2017-06-27
KR20150021509A (ko) 2015-03-02
RU2015100257A (ru) 2016-08-10
CA2875212A1 (en) 2013-12-19
US20150290240A1 (en) 2015-10-15
WO2013188528A1 (en) 2013-12-19
EP2861718A4 (en) 2016-03-23
HK1209782A1 (en) 2016-04-08
JP2015527975A (ja) 2015-09-24
MX2014014524A (es) 2015-02-24
CN104471058A (zh) 2015-03-25

Similar Documents

Publication Publication Date Title
JOP20180102B1 (ar) مركب صيدلاني
GEP201706695B (en) Substituted 4-phenyl-pyridi-nes for the treatment of nk-1 receptor related diseases
PH12014502757B1 (en) Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
MD20150091A2 (ru) Противовирусные соединения
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
HK1206387A1 (en) Organic compositions to treat kras-related diseases kras
MX348325B (es) Composicion que contiene galacto-oligosacarido y un metodo para producirla.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
MY166449A (en) Pharmaceutical composition of rosuvastatin calcium
PH12016500054A1 (en) Substituted pyrazolo-pyridinamines
IL239535A0 (en) The compositions for whitening with controlled release
PH12015502747A1 (en) Novel compounds for the treatment of cancer
EP2794806A4 (en) AZEOTROPÄHNLICHE COMPOSITIONS WITH CIS-1-CHLORO-3,3,3-TRIFLUORPROPEN
IL237483A0 (en) Preparations for the treatment of psoriasis
MX2015008187A (es) Inhibidores de alk deuterados.
CL2014001471A1 (es) Composiciones anhidro antitranspirantes; metodo para reducir transpiracion; y metodo de fabricación de dicha composicion.
IN2014MN02391A (ru)
IN2015DN00833A (ru)
EA201491581A1 (ru) Везикулярные композиции
IN2014DN03245A (ru)
EP2651429A4 (en) NEUROPEPTIDE ANALOGUES, COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN
EA201591449A1 (ru) Способы получения противораковых композиций
WO2012158493A3 (en) Compounds that bind to the erythropoietin receptor
EP2926817A4 (en) STABLE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OSTEOPOROSIS
MX2015007460A (es) Agentes para el tratamiento del dolor y usos de los mismos.